Discontinuation of Low-Dose Aspirin Therapy After Peptic Ulcer Bleeding Increases Risk of Death and Acute Cardiovascular Events

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 1, 2013, Pages 38-42

  Derogar, Maryam ^a   Sandblom, Gabriel ^a,b   Lundell, Lars ^a,b   Orsini, Nicola ^a   Bottai, Matteo ^a   Lu, Yunxia ^a   Sadr Azodi, Omid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PEPTIC ULCER BLEEDING; RETROSPECTIVE STUDY;

AGED; ASPIRIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PEPTIC ULCER; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN; WITHHOLDING TREATMENT;

EID: 84870891069     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.08.034     Document Type: Article

References (16)

1. Malfertheiner P., Chan F.K., McColl K.E. Peptic ulcer disease. Lancet 2009, 374:1449-1461.
2. Lassen A., Hallas J., Schaffalitzky de Muckadell O.B. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006, 101:945-953.
3. van Leerdam M.E., Vreeburg E.M., Rauws E.A., et al. Acute upper GI bleeding: did anything change?. Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/ 1994 and 2000. Am J Gastroenterol 2003, 98:1494-1499.
4. Bardhan K.D., Williamson M., Royston C., et al. Admission rates for peptic ulcer in the Trent region, UK, 1972-2000: changing pattern, a changing disease?. Dig Liver Dis 2004, 36:577-588.
5. Weil J., Langman M.J., Wainwright P., et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000, 46:27-31.
6. Kang J.Y., Elders A., Majeed A., et al. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006, 24:65-79.
7. Loperfido S., Baldo V., Piovesana E., et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009, 70:212-224.
8. Sostres C., Lanas A. Should prophylactic low-dose aspirin therapy be continued in peptic ulcer bleeding?. Drugs 2011, 71:1-10.
9. Sung J.J., Chan F.K., Chen M., et al. Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding. Gut 2011, 60:1170-1177.
10. Sung J.J., Lau J.Y., Ching J.Y., et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010, 152:1-9.
11. Heldwein W., Schreiner J., Pedrazzoli J., et al. Is the Forrest classification a useful tool for planning endoscopic therapy of bleeding peptic ulcers?. Endoscopy 1989, 21:258-262.
12. Salas M., Hofman A., Stricker B.H. Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol 1999, 149:981-983.
13. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 150:396-404.
14. Baigent C., Blackwell L., Collins R., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009, 373:1849-1860.
15. Sostres C., Lanas A. Gastrointestinal effects of aspirin. Nat Rev Gastroenterol Hepatol 2011, 8:385-394.
16. Barkun A.N., Bardou M., Kuipers E.J., et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010, 152:101-113.